Win at DIA 2017!

The Ziggy Photo Competition is back!

19-21 June 2017 | Chicago, IL, USA

Come and join us at booth #529 to discuss all your QA requirements, receive your free Zigzag Zebra and enter our Ziggy Photo Competition!

Our company mascot has got a brand-new look for 2017 and we've decided to celebrate with a Chicago themed #ZiggyPics Photo Competition! Our Zebra travels the world with our auditors documenting his travels via social media and now it's your chance to get involved.

Whilst at the conference, head to booth #529 to receive all the details and to collect your Zigzag Zebra. Due to popular demand our zebras go quick so be fast.

The best photo will be judged by our UK Office and the winner, who will be announced at the end of the conference via our social media, will win a prize!

Whilst at our booth our team will be happy to discuss any of your QA requirements and answer any questions you may have.

Take a look at previous years entries on our Facebook page for inspiration.

We look forward to seeing you in Chicago - get snapping!


We received some incredible entries this year. Our winner was Darby Stephens with the below shot.

We also loved Meg's shot of her daughter so much that we had to send her a runner up prize. See the full story here

Here are some of the other great entries! A huge thank you to all who entered. See you next year!

#DIA2017 #competition #win #ziggypic #zigzagassociates #conference #exhibition #pharma #photocompetition


Recent Posts

See All

Conducting Pharmacovigilance audits during COVID-19

Considering the current global health pandemic known as COVID-19, the pharmaceutical industry has a real life scenario to test out the business continuity planning of the Pharmacovigilance (PV) operat

EMA COVID-19 Guidance and Auditing activities

With the outbreak of the COVID-19 virus the European Medicines Agency (EMA) issued guidance on 20th March 2020 for conducting Clinical Trials during the Pandemic. While the guidance was primarily focu

Deciding to audit remotely?

Drug companies are continuously striving to reduce and streamline clinical drug development. However, with the current pandemic precautions, increasing pressures to reduce climate impact, political un